Regeneron Pharmaceuticals Inc

Company Snapshot
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 11,851
https://www.regeneron.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$7,377,200,000
$13,634,200,000
$10,612,500,000
Operating Income
$3,576,600,000
$8,946,800,000
$4,994,000,000
Net Income
$3,513,200,000
$8,075,300,000
$4,338,400,000
2020
Gross Profit
$7,377,200,000
Operating Income
$3,576,600,000
Net Income
$3,513,200,000
2021
Gross Profit
$13,634,200,000
Operating Income
$8,946,800,000
Net Income
$8,075,300,000
2022
Gross Profit
$10,612,500,000
Operating Income
$4,994,000,000
Net Income
$4,338,400,000
The above data on Regeneron Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Andrew Murphy
Executive Vice President Research
$1,598,250
$7,499,579
$24,700
$9,122,529
Andrew Murphy
$9,122,529
Executive Vice President Research
Daniel Van Plew
Executive Vice President and General Manager, Industrial Operations and Product Supply
$1,917,900
$6,899,138
$36,499
$8,853,537
Daniel Van Plew
$8,853,537
Executive Vice President and General Manager, Industrial Operations and Product Supply
Robert Landry
Executive Vice President Finance and Chief Financial Officer
$1,814,760
$6,999,033
$24,700
$8,838,493
Robert Landry
$8,838,493
Executive Vice President Finance and Chief Financial Officer
Leonard Schleifer
Director, Co-President and Chief Executive Officer
$5,943,344
$0
$1,060,725
$7,004,069
Leonard Schleifer
$7,004,069
Director, Co-President and Chief Executive Officer
Marion McCourt
Executive Vice President Commercial
$1,486,762
$5,399,677
$13,500
$6,899,939
Marion McCourt
$6,899,939
Executive Vice President Commercial
Regeneron Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us